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Abstract
Background: ABCA3 transporter (ATP-binding cassette transporter of the A subfamily) is localized to the limiting
membrane of lamellar bodies, organelles for assembly and storage of pulmonary surfactant in alveolar epithelial
type II cells (AECII). It transports surfactant phospholipids into lamellar bodies and absence of ABCA3 function
disrupts lamellar body biogenesis. Mutations of the ABCA3 gene lead to fatal neonatal surfactant deficiency and
chronic interstitial lung disease (ILD) of children. ABCA3 mutations can result in either functional defects of the
correctly localized ABCA3 or trafficking/folding defects where mutated ABCA3 remains in the endoplasmic
reticulum (ER).
Methods: Human alveolar epithelial A549 cells were transfected with vectors expressing wild-type ABCA3 or one
of the three ABCA3 mutant forms, R43L, R280C and L101P, C-terminally tagged with YFP or hemagglutinin-tag.
Localization/trafficking properties were analyzed by immunofluorescence and ABCA3 deglycosylation. Uptake of
fluorescent NBD-labeled lipids into lamellar bodies was used as a functional assay. ER stress and apoptotic signaling
were examined through RT-PCR based analyses of XBP1 splicing, immunoblotting or FACS analyses of stress/
apoptosis proteins, Annexin V surface staining and determination of the intracellular glutathion level.
Results: We demonstrate that two ABCA3 mutations, which affect ABCA3 protein trafficking/folding and lead to
partial (R280C) or complete (L101P) retention of ABCA3 in the ER compartment, can elevate ER stress and
susceptibility to it and induce apoptotic markers in the cultured lung epithelial A549 cells. R43L mutation, resulting
in a functional defect of the properly localized ABCA3, had no effect on intracellular stress and apoptotic signaling.
Conclusion: Our data suggest that expression of partially or completely ER localized ABCA3 mutant proteins can
increase the apoptotic cell death of the affected cells, which are factors that might contribute to the pathogenesis
of genetic ILD.
Background
ABCA3 is a member of the ATP-binding cassette (ABC)
family of transporters which utilize the energy of ATP
hydrolyses to drive the transport of a variety of
substrates across biological membranes [1]. The ABCA3
gene is highly expressed in alveolar epithelial type II
cells (AECII) of the lung [2,3]. In AECII ABCA3 protein
localizes to the limiting membrane of lamellar bodies as
lipid-rich organelles for production, storage and
secretion of pulmonary surfactant [4,5]. Surfactant is a
complex mixture of 90% lipids (mostly phospholipids)
and 10% surfactant-specific proteins (e.g. small hydro-
phobic proteins SP-B and SP-C) produced by AECII
which reduces surface tension on the air-liquid interface
a n dp r e v e n t sa l v e o l a rc o l l a p s ea tt h ee n do fe x p i r a t i o n .
ABCA3 is a lipid transporter which transports surfactant
phospholipids into lamellar bodies where surfactant is
assembled. It is essential for lamellar body biogenesis
[6-9] so patients with ABCA3 mutations and Abca3
knock-out mouse have distinctive dense inclusions
within immature lamellar bodies and disturbed composi-
tion of surfactant phospholipids [7,8,10-13]. Since the
last steps in SP-B and SP-C processing occur inside of
functional lamellar bodies, ABCA3 deficiency in human
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precursors [7,8,14,15].
In 2004 mutations of the ABCA3 gene were recog-
nized as a cause of lung diseases in full-term neonates
with fatal pulmonary surfactant deficiency [10]. Today
ABCA3 mutations are known to cause also chronic
interstitial lung disease (ILD) in children and older
patients [12,16,17]. With more than 100 identified muta-
tions, ABCA3 is the most frequent known cause of
genetic ILD (own unpublished data), [12,16,17]. Similar
to SP-C deficiency, ABCA3-related ILD is complex and
heterogeneous in histopathology and symptom severity.
The disease onset varies from directly after birth, early
in infancy or later in childhood [10,12,16,18,19], some-
times following the exposure to environmental stressors
such as cigarette smoke [12,16].
ABCA3 mutations classify either as functional defects
of properly localized proteins or trafficking/folding
defects where misfolded proteins accumulate in the ER
[6,20]. Folding of newly synthesized proteins is a highly
controlled process happening in the ER lumen with
assistance of molecular chaperones. Proteins which fail
to fold properly are harmful for the cell and retained
inside the ER by the ER quality control. ER accumula-
tion of misfolded proteins causes ER stress and activates
cytoprotective mechanisms named unfolded protein
response (UPR). UPR promotes the ER protein folding
capacity by increasing the production of molecular cha-
perones and attenuates general protein translation to
decrease the misfolded protein load in the ER [21]. If
UPR fails to resolve ER stress and restore cell homeosta-
sis, the cell will be eliminated by initiation of tightly
controlled apoptotic cell-death pathways [22].
Recent data show that ER stress and apoptosis of
AECII play a role in lung disease, especially in patho-
genesis of idiopathic pulmonary fibrosis (IPF) and
genetic SP-C-associated pulmonary fibrosis [23-26].
Moreover, cultured lung epithelial A549 cells expressing
SP-C mutations, which cause misfolding and aggrega-
tion of the SP-C pre-protein, increase ER stress, activate
UPR and initiate apoptotic cell-death [26-28]. Fibrosis is
one of the hallmarks documented in ABCA3-associated
ILD [12,16,17] and knowing that ABCA3 mutations can
cause ER retention of the mutated transporter [6,20],
we investigated the influence of three ABCA3 muta-
tions, R43L, R280C and L101P, found in children with
surfactant deficiency and chronic ILD [10,14,19], on
ER stress and apoptosis induction in lung epithelial
A549 cells.
Methods
Plasmid Vectors
Wild type (WT) full length human hABCA3 cDNA
without stop codon was cloned into EcoRI/AgeIs i t e so f
pEYFP-N1 plasmid (Clontech, Mountain View, CA)
to obtain pEYFP-N1/WT vector for expression of C-
terminal ABCA3-YFP protein fusions. pUB6-HA/WT
vector for expression of C-terminal fusions of ABCA3
with hemagglutinin tag (HA-tag) was produced by mod-
ification of pUB6/V5-His vector (Invitrogen, Karlsruhe,
Germany). His-tag was put out of frame and WT
hABCA3 cDNA with 3’ HA-tag sequence (5’-TAC CCA
TAC GAT GTT CCA GAT TAC GCT-3’) was cloned
into KpnI/XhoI restriction sites. Three hABCA3 point
mutations R43L, R280C and L101P were introduced in
the WT ABCA3 in both vector types by PCR-based site-
directed mutagenesis (QuickChange Site-Directed Muta-
genesis, Stratagene, La Jolla, CA). Mutagenesis primers
were as follows: R43L-For 5’-CAT CTG GCT CCTCTT
GAA GAT TC-3’, R43L-Rev 5’-GAA TCT TCA
AGAG G AG C CA G AT G - 3 ’, L101P-For 5’-CAG TGC
GCA GGG CAC CTG TGA TCA AC-3’, L101P-Rev 5’-
GTT GAT CAC AGG TGC CCT GCG CAC TG-3’,
R280C-For 5’-CAT TGC CTG TGC TGT CGT G-3’,
R280C-Rev 5’-CAC GAC AGC ACAGGC AAT G-3’.
Successful mutagenesis in pEYFP-N1/ABCA3 and
pUB6-HA/ABCA3 (ABCA3 denotes WT or one of the
three mutations) was confirmed by sequencing.
Cell Culture and Transfection
Human lung carcinoma epithelial cell line A549 (ACC
107) was obtained from the German Collection of
Microorganisms and Cell Cultures (DSMZ, Braunsch-
weig, Germany). Cells were grown in RPMI 1640 med-
ium with 10% FBS. At 70% confluence cells were
transiently transfected with pEYFP-N1/ABCA3 or
pUB6-HA/ABCA3 vectors using ExGen 500 (Fermentas,
Burlington, ON) according to the manufacturer’s proto-
col. 48 h after transfection samples were collected for
experiments. Transfection efficiency was confirmed in
all samples through YFP signal or immunofluorescence
of HA-tag (see bellow). ABCA3 construct expression
was similar in all transfected cells as assessed by ABCA3
mRNA and protein expression levels. ABCA3 mRNA
expression after transfection strongly increased
(>30-fold) compared to non-transfected A549 cells (data
not shown). When indicated transfected cells were incu-
bated 14 h with 10 μg/ml of tunicamycin (Sigma,
St. Louis, MO) or 16 h with 25 ng/ml of TNFa (Invitrogen)
prior to sample collection.
Immunofluorescence
Cells grown on coverslips were transfected with pEYFP-
N1/ABCA3 or pUB6-HA/ABCA3 vectors, washed in
PBS buffer, fixed in 4% paraformaldehyde, permeabilised
and incubated 1 h at room temperature with the follow-
ing primary antibodies: monoclonal mouse anti-LAMP3/
CD63 (1:200, Chemicon, Tamecula, CA), polyclonal goat
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Cruz, CA) and to detect HA-tagged ABCA3 monoclonal
rat anti-HA-tag (1:200, Roche, Manheim, Germany).
Signals were visualized with Alexa Fluor 555 anti-goat
or Alexa Fluor 555 anti-mouse IgG secondary antibodies
(1:200, Invitrogen). Alexa Fluor 555 and YFP fluores-
cence of mounted samples was examined with Axiovert
135 fluorescent microscope and evaluated with AxioVi-
sion 4.7.1 software (Carl Zeiss, Jena, Germany).
Immunoblotting
Cells were collected and resuspended in lysis buffer
(0.15 M NaCl, 1% Triton-X100, 0.5% sodium deoxycho-
late, 50 mM Tris, 5 mM EDTA) supplied with protease
inhibitor cocktail (Complete; Roche). 30 μg of total pro-
tein was transferred to a PVDF membrane and immuno-
blotted with the following primary antibodies:
monoclonal mouse anti-GFP (1:500, Clontech), mono-
clonal rabbit anti-BiP/Grp78 (1:1000, Cell Signaling,
Frankfurt, Germany), monoclonal mouse anti-caspase 4
(1:500, Stressgene), and monoclonal mouse anti-b-actin
HRP conjugate (1:10000, Santa Cruz). Signal was
detected using chemiluminiscent labeling with Amer-
sham ECL Detection Reagents (GE Healthcare, Buckin-
ghamshire, UK).
Membrane Isolation and Deglycosylation Assay
For crude membrane preparation cells transfected with
pEYFP-N1/ABCA3 vectors were collected in PBS
supplemented with 1 mM EDTA and protease inhibitor
(Complete, Roche). Cells were broken in a Potter-Elveh-
jem homogenizer and subsequently sonicated (Branson
Digital Sonifier S450D) while keeping the samples on
ice. Samples were centrifuged at 1000 × g, 10 min, 4 °C
and obtained postnuclear supernatants were centrifuged
at 100 000 × g, 1 h, 4 °C. Membrane pellets were resus-
pended in 25 mM Hepes/NaOH, pH 7.0 with protease
inhibitor and stored at -80°C. For the deglycosylation
assay 5 μg of membranes were incubated 1 h at 37 °C
with PNGaseF or EndoH (New England Biolabs,
Ipswich, MA). The samples were separated on 3-8%
SDS-PAGE gels (NuPAGE; Invitrogen) and immuno-
blotted with monoclonal mouse anti-GFP antibody
(1:500, Clontech).
Liposome Preparation and NBD-Lipid Uptake
NBD-labeled lipids phosphatidylcholine (C12-NBD-PC)
and phosphatidylethanolamine (C12-NBD-PE) were
purchased from Avanti Polar Lipids (Alabaster, AL),
other lipids from Sigma. Liposome preparation and
NBD-lipid uptake were performed following previously
published protocols [6]. Liposomes (~100 nm) contain-
ing C12-NBD-PC or C12-NBD-PE were prepared by
mixing lipids in chloroform in the following molar
ratios: L-aDPPC: C12-NBD-PC: egg PC: egg PG: choles-
terol = 5:5:5:3:2 and L-aDPPC: egg PC: egg PG: choles-
terol: C12-NBD-PE = 10:5:3:2:2. Cells grown on
coverslips were transfected with pUB6-HA vectors
expressing ABCA3 WT or one of the three mutations.
48 h later cells were incubated for 2 h with liposomes
so that the final concentration of C12-NBD-PC or C12-
NBD-PE in the medium was 150 μM. Cells were washed
three times with PBS and prepared for immunofluores-
cence with primary monoclonal rat anti-HA-tag anti-
body (1:200, Roche) and secondary anti-rat IgG Alexa
Fluor 555 antibody (1:200, Invitrogen). NBD-lipid uptake
was examined with an Olympus FluoView FV 1000
confocal microscope.
RT-PCR and XBP1 Splicing
A549 cells were transfected with YFP vectors and where
indicated treated 14 h with 10 μg/ml of tunicamycin
(Sigma). 48 h after transfection total RNA was isolated
(High Pure RNA Isolation Kit, Roche) and cDNA was
synthesized (SuperScript III First-Strand Synthesis
System, Invitrogen). For every RNA sample a control
reaction without reverse transcriptase was performed to
exclude genomic DNA contamination. cDNA was
further used as a template for PCR with XBP1 and 18S
rRNA primers as published in [29]. For easier evaluation
half of the PCR product was digested with PstIe n d o n u -
clease cutting only inside of the 26 nt intron removed
from the XBP1 mRNA by splicing. Cut and uncut PCR
products were analyzed on a 3% agarose gel. Results
were calculated as the ratio of the spliced (s) and
unspliced (u) band (s/u; without PstId i g e s t i o n )a n d
additionally confirmed by calculating the ratio of the
spliced band and the sum of the two PstId i g e s tb a n d s
(s/(u1+u2), with PstI digestion). Hybrid band (h) was
considered as equally contributing to unspliced and
spliced bands.
FACS Analyses
Cells transfected with pEYFP-N1/ABCA3 vectors were
gated in the FL-1 channel (YFP-positive population of
cells) and apoptosis was determined using different
approaches. Early apoptosis was assayed by 1) measuring
intracellular glutathione (GSH) levels with the cell-
permeable monochlorobimane (Sigma) method [30] and
2) by annexin V
+/propidium iodide (PI)
- staining
(Cy5-conjugated anti-annexin V and PI; BD Bioscience,
Heidelberg, Germany), and late apoptosis was deter-
mined via intracellular active caspase 3 levels (PE-conju-
gated anti-active-caspase 3; BD Bioscience) in cells
permeabilized with the IntraPrep kit (Beckman Coulter,
Krefeld, Germany) according to the manufacturer’s pro-
tocol. To exclude unspecific binding isotype controls for
caspase 3 and negative controls for glutathione and
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Flow Cytometer was used for the assay and FACSDiva
v6.1.3 for data analyses (BD Bioscience).
Statistical Analyses
Statistical analysis was performed by one-way ANOVA
and Bonferroni’s test using GraphPad Prism version 4.0
(GrapPad Software Inc., San Diego, CA). All results
were presented as means ± SEM of minimum four
experiments and p-values < 0.05 were considered
significant.
Results
General characterization of R43L, R280C and L101P
ABCA3 mutations
A) Localization and trafficking
Three clinically relevant ABCA3 mutations identified in
patients with neonatal surfactant deficiency (R43L and
L101P) and chronic ILD (R280C) were chosen for the
study. While cell biology of R43L and R280C mutations
has not been studied yet, L101P mutation was pre-
viously described as a trafficking/folding defect resulting
in the ER accumulation of L101P protein [6,20] and was
deliberately chosen for this study as a cause for the
ABCA3 ER retention.
Initially we investigated intracellular localization of the
WT and R43L, R280C and L101P transporters. We
transfected A549 cells with two types of vectors expres-
sing YFP (pEYFP-N1/ABCA3) or HA tagged ABCA3
(pUB6-HA/ABCA3). Fluorescence microscopy of A549
cells expressing either type of protein fusions showed no
differences in the protein behavior depending on
the type of the vector or the size of the protein tag
(Figure 1A, B and 1C). WT protein colocalized with
lysosomal-associated membrane protein 3 (LAMP3), a
marker for lamellar bodies and lamellar-body-like vesi-
cles (Figure 1A) [5,6,20]. Similar was observed for the
R43L mutant, which showed a vesicular signal that over-
lapped with LAMP3 fluorescence (Figure 1A). For both
W Ta n dR 4 3 Lm u t a n t ,v e r yl i t t l et on oc o l o c a l i z a t i o n
was detected with calnexin (Figure 1B). WT and R43L
might colocalize with the ER-resident protein calnexin
during their folding in the ER as expected during the
protein maturation process. R280C protein colocalized
frequently with LAMP3, however the colocalization was
not absolute, showing often cytoplasmic distribution
that overlapped with the fluorescence of calnexin
(Figure 1A, B). L101P mutation did not show any vesi-
cular signal at all (Figure 1A) but presented with a cyto-
plasmic fluorescence mainly colocalizing with the ER
protein calnexin (Figure 1B). This suggests correct loca-
lization of the WT and R43L transporters in the
LAMP3-positive (LAMP3
+) vesicles and almost full
retention of the L101P mutant in the ER, possibly as a
result of protein misfolding. Dual localization of R280C
protein might be a sign of hindrance in the processing
and folding of this mutant which slows down but does
not abolish its progress through the ER, Golgi and
toward LAMP3
+ vesicles.
B) Processing and maturation
In immunoblots with anti-GFP antibody on cell lysates
from transfected A549 cells expressing YFP labeled WT,
R43L and R280C proteins, two protein bands of 180
kDa (150 kDa ABCA3 plus 30 kDa YFP) and 220 kDa
(190 kDa ABCA3 plus 30 kDa YFP) were detected
( F i g u r e2 A ) .T h e ym i g h tr e p r e s e n tA B C A 3p r o c e s s i n g
forms, as previously suggested, with the active ABCA3
form still unknown [6,20,29]. The processing of ER
retained L101P protein was different, showing complete
lack of the 180 kDa band, in line with published data
(Figure 2A) [6,20].
ABCA3 is a glycoprotein that obtains high-mannose
oligosaccharides inside the ER and complex oligosac-
charides by modification of high-mannose oligosacchar-
ides in the Golgi. Processing of oligosaccharides and
protein progress down the ER-Golgi maturation pathway
Figure 1 Intracellular localization of the WT and mutant R43L,
R280C and L101P ABCA3 proteins. A549 cells were transiently
transfected with pEYFP-N1/ABCA3 vectors expressing WT or one of
the three mutations. YFP fluorescence of ABCA3-YFP fusions (green)
was used to detect ABCA3 WT and R43L, R280C and L101P proteins.
Colocalization of the ABCA3-YFP signal with the fluorescent signal
of (A) the lysosomal/lamellar body protein LAMP3 and (B) the ER
protein calnexin (both red) are shown. WT and R43L localized in
LAMP3
+ vesicles, R280C partially in LAMP3
+ vesicles and partially in
the ER and L101P completely in the ER. (C) Partial ER localization of
HA-tagged R280C in A549 cells transfected with pUB6/HA-R280C
plasmid confirms the partial R280C ER retention as independent on
the type of the plasmid or protein tag. Representative pictures are
shown; scale bars: 5 μm.
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from A549 cells expressing ABCA3 WT and three
mutations with two endoglycosidases EndoH (cleaves
only high-mannose sugars) and PNGaseF (cleaves
high-mannose and complex sugars) (Figure 2B). Immu-
noblotting with anti-GFP antibody revealed absence of
complex sugars in L101P protein that was susceptible to
both enzymes, PNGaseF and EndoH, resulting in both
cases in a single shifted deglycosylated 210 kDa band
and no 220 kDa band. Both sugar types were present in
WT, R43L and R280C proteins, as visible by the resis-
tance of a portion of the 220 kDa band to the EndoH
treatment. The 180 kDa band was resistant to deglyco-
sylation (Figure 2B). This confirms the localization stu-
dies showing retention of the L101P mutant in the ER
and ability of WT, R43L and R280C to progress further
from the ER to the Golgi.
C) Functional assay
Trafficking/folding defect and ER accumulation of
L101P protein exclude the ABCA3 function in the case
of this mutant. However, R43L and R280C mutation are
mostly (R280C) or completely (R43L) correctly localized
and potentially functional (Figure 1A, B). Therefore, we
undertook a functional study of uptake of fluorescently
NBD-labeled lipids into the lamellar-body-like vesicles
in A549 cells transfected with pUB6-HA/ABCA3 plas-
mids (Figure 3). Liposomes containing NBD-labeled
major surfactant phospholipid phosphatidyl-choline
(C12-NBD-PC) and NBD-labeled minor surfactant
phospholipid phosphatidylethanol-amine (C12-NBD-PE)
were incubated with A549 cells expressing WT, R43L,
R280C and L101P HA-tagged proteins. L101P mutant
was used to monitor the situation with nonfunctional
ABCA3 protein. Colocalization of the fluorescent signal
of C12-NBD-PC or C12-NBD-PE (green) with ABCA3-
HA-positive vesicles (red), which normally colocalized
with LAMP3 (Figure 1A), was monitored by confocal
microscopy.
Interestingly, uptake of fluorescent liposomes into
A549 cells was prominent in all cells, including those
expressing L101P mutants (Figure 3) and therefore
Figure 2 Processing of the WT and mutant R43L, R280C and
L101P ABCA3. (A) Immunodetection with anti-GFP antibody
showed two ABCA3 protein bands (180 kDa and 220 kDa) in whole
cell lysates of A549 cells expressing WT and R43L and R280C
mutations, and only one protein band in the cells expressing L101P
mutation. (B) Deglycosylation assay with PNGaseF and EndoH on
the membrane fractions from A549 cells transfected with pEYFP-N1/
ABCA3 plasmids and subsequent ABCA3-YFP immunodetection with
anti-GFP antibody showed presence of high-mannose and complex
oligosaccharides in WT, R43L and R280C proteins, as well as only
high-mannose and no complex oligosaccharides in the L101P
mutant resulting from the L101P ER retention.
Figure 3 Function of the R43L and R280C transporters.( A - C )
Uptake of C12-NBD-phospholipids PC and PE into ABCA3 vesicles in
A549 cells transfected with pUB6/HA-ABCA3 vectors was studied by
confocal microscopy. Transfected cells were incubated for 2 h with
(A) C12-NBD-PC and (B) C12-NBD-PE containing liposomes (150 μM
of NBD-lipid). HA-tag was used to detect ABCA3 WT and R43L,
R280C and L101P by immunofluorescence (red). Both C12-NBD-PC
and C12-NBD-PE fluorescence (green) frequently colocalized with the
ring-like ABCA3 WT signal as well as within the ABCA3-WT vesicles
and almost never with the R43L and R280C vesicles. In small
sections and in (C) uptake into ABCA3-WT vesicles of both NBD-
lipids PC and PE is depicted closer. Uptake through the plasma
membrane into the cytoplasm of L101P transfected cells with no
functional exogenous ABCA3 was observed as well as numerous
cytoplasmic NBD-positive liposome-like vesicles in all A549 cells
independent of the ABCA3 mutation shown in (A) and (B). (D)
Influence of WT ABCA3 and three mutations on biogenesis of
LAMP3
+ vesicles in A549 transfected with pUB6/HA-ABCA3. WT
ABCA3 (green) induced biogenesis of LAMP3
+ vesicles (red)
increasing their number and size in A549 cells, while R43L, R280C
and L101P proteins showed no such effect (the same was observed
in A549 pEYFP-N1/ABCA3 transfected cells - not shown).
Representative pictures are shown; scale bars: 5 μm.
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not shown), showing numerous NBD-positive vesicular
structures dispersed throughout the cytoplasm (Figure 3).
This confirms that lipid/liposome uptake into the cyto-
plasm through the plasma membrane does not depend
on functional ABCA3, and that ABCA3 is solely an intra-
cellular vesicular lipid transporter.
WT-ABCA3-HA signal formed ring-like structures,
consistent with the localization of ABCA3 in the limit-
ing membrane of lamellar bodies. Both NBD-PC and
NBD-PE fluorescent signals were often visible as a punc-
tual signal merging with this ring-like border of
WT-ABCA3-HA vesicles (Figure 3A, B and 3C). Also,
accumulation of the weaker diffuse green NBD signal
was frequently observed within the inner space of
WT-ABCA3-HA vesicles (Figure 3C and small sections
in Figure 3A, B). Similar colocalization of NBD fluores-
cence with ABCA3-HA vesicles was extremely rarely
observed in cells expressing R43L and R280C mutations
(Figure 3A, B). This probably indicates the ability of
WT-ABCA3-HA vesicles to take up and accumulate
both fluorescent lipids, while R280C-ABCA3-HA and
R43L-ABCA3-HA vesicles did not show such ability.
D) Biogenesis of LAMP3
+ vesicles
Expression of WT or three mutations exhibited different
effects on biogenesis of the LAMP3
+ vesicles in A549
cells. In A549 cells, that normally show a low number
of small LAMP3
+ vesicles, expression of WT-ABCA3
significantly induced biogenesis of numerous big vesicles
with ring-like signals of ABCA3 fluorescence (equally
from pEYFP-N1 or pUB6-HA vectors). Expression of
R43L, R280C and L101P mutations had a negative effect
on vesicle formation and induced a lower number of
smaller compact LAMP3
+ vesicles, with the most drastic
effect in L101P mutant (Figure 3D). This again proves
the role of ABCA3 in lamellar body biogenesis [6,7,29].
Decreased uptake of NBD fluorescence in lamellar
bodies and impact on lamellar body biogenesis together
suggest functional impairment of the R43L and R280C
proteins.
L101P and R280C mutation upregulate ER stress marker
BiP
BiP/Grp78 is an essential ER chaperone of the Hsp70
family, which assists the translocation of a nascent pro-
tein chain into the ER and its subsequent folding. When
misfolded proteins accumulate in the ER, BiP upregula-
tion is one of the first signals of ER stress and allows
further UPR activation [30]. Immunoblotting of whole
cell lysates from A549 cells expressing ABCA3-WT and
three mutants revealed significant upregulation of BiP
chaperone in the case of L101P mutation and R280C
mutation in comparison to WT, caused by complete
(L101P) or partial ER retention (R280C) of these two
mutated ABCA3 transporters (Figure 4A, B). No signifi-
cant BiP increase was detectable between WT and cor-
rectly localized R43L mutation. While treatment of
A549 cells with a potent ER stress-causing antibiotic
tunicamycin (TM) caused drastic BiP upregulation in
A549 cells, differences measured between WT and three
mutations were more subtle.
L101P and R280C mutations increase susceptibility of
A549 cells to ER stress
Upon ER accumulation of misfolded proteins BiP dis-
sociates from the luminal domain of IRE1, allows IRE1
dimerization and synthesis of active XBP1 protein, a
UPR transcription factor which regulates expression of
ER stress proteins including BiP. XBP1 activation is
regulated on the level of splicing of a 26 nt intron from
the XBP1 mRNA by endoribonuclease activity of the
IRE1 dimer [31]. To confirm previous observation on
Figure 4 Increase in the ER stress chaperone BiP in A549 cells
expressing R280C and L101P mutations. (A) A549 cells with ER
retained L101P mutant or partially ER retained R280C protein
showed upregulation of the immunodetected ER chaperone BiP in
comparison to WT and A549 cells. BiP was drastically upregulated
after 14 h treatment of A549 cells with 10 μg/ml of the ER stressor
tunicamycin (TM). (B) Densitometric quantification of the BiP protein
level of four independent experiments, without the drastic effect of
TM treatment, is presented; * p < 0.05, ** p < 0.01.
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assayed splicing of the XBP1 mRNA by RT-PCR [32].
We have measured the ratio of spliced (s; ~500 bp - 26
bp) and unspliced (u; ~500 bp) XBP1 RT-PCR bands,
prior and after the treatment of the PCR products with
PstI restriction endonuclease, as a measuring control. A
slower migrating hybrid (h) band of unspliced and
spliced single-stranded DNAs produced during PCR,
and thus equally contributing to unspliced and spliced
bands, was observed as well after the long-run separa-
tion on 3% agarose (Figure 5A) [33]. Tunicamycin treat-
ment strongly increased the intensity of the spliced PCR
band in A549 cells in comparison to untreated A549
(Figure 5C). In A549 cells with either WT or one of the
three mutations, increase of XBP1 splicing was mea-
sured only in the case of L101P mutation (Figure 5D).
Probably because of the robustness of the method, finer
differences between WT and R43L and R280C were not
o b s e r v a b l e ,a n dt h ee f f e c tw a sm e a s u r a b l eo n l yi nt h e
case of the L101P mutant with the strongest protein
defect (Figure 5A, D).
To intensify the stress and to investigate the suscept-
ibility of cells with ABCA3 mutations to external ER
stress-causing agents, transfected cells were exposed to
10 μg/ml of tunicamycin, an inhibitor of N-linked glyco-
sylation (Figure 5B, E). The outcome of such double
internal genetic and external tunicamycin pressure on
XPB1 splicing was examined. Tunicamycin treatment
Figure 5 Susceptibility of A549 cells with ABCA3 mutations to ER stress measured by XBP1 splicing. XBP1 activation during UPR is
regulated on the level of splicing of a 26 nt intron from the XBP1 mRNA. (A) XBP1 splicing in untransfected A549 cells with and without
tunicamycin (TM) treatment (10 μg/ml, 14 h) and in A549 cells with R43L, R280C and L101P mutations. Two PCR products were detected by RT-
PCR: u - unspliced and s - spliced XBP1 bands. h denotes a hybrid band between unspliced and spliced ssDNA produced during PCR and
observed after long-run separation on 3% agarose (upper panel) (21). For easier densitometric evaluation and to ensure good separation
between unspliced and hybrid band, half of the PCR products were cut by PstI endonuclease which cuts only unspliced (u) band giving two
bands u1 and u2 (middle panel). Control reactions without reverse transcriptase (-RT) are shown as well. (C, D) Densitometric quantification of
the bands (s, u) in (A) from the middle panel (PstI digest), presented as the ratio s/(u1+u2). TM highly elevated XBP1 splicing in A549 cells. Lower
effect of L101P mutation on XBP1 splicing in A549 cells and no effect in A549 with WT and R43L and R280C mutations were observed. (B, E) TM
treatment (10 μg/ml, 14 h) strongly induced XBP1 splicing (disappearance of unspliced bands u1 and u2) in all A549 cells expressing ABCA3
mutations, with the most significant increase in A549 expressing R280C and L101P mutations (increase in spliced band s). Shown are (B) 3%
agarose gel after PstI digestion of the RT-PCR products (upper panel) and 18S rRNA (lower panel), and (E) densitometric evaluation of the bands.
Presented graphs are the densitometric quantification of four independent experiments; * p < 0.05, ** p < 0.01.
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in A549 and WT cells (Figure 5E). However, after expo-
sure to tunicamycin XBP1 splicing was considerably
more pronounced in R280C and L101P mutations if
compared to A549 cells with WT and R43L mutations
(Figure 5B, E). Obviously, although XBP1 splicing was
measurable only for the strongest L101P defect under
non-stimulated condition, cells with L101P and R280C
mutations were significantly more prone to further
elevation of ER stress upon exposure to an external
stressor.
L101P and to a lesser extent R280C mutation induce
apoptosis of A549 cells
Since prolonged ER stress can activate apoptosis, we
analyzed if ABCA3 mutations can induce early and late
apoptotic markers in A549 cells. In all experiments YFP
fluorescence was utilized to determine the population of
transfected cells (YFP
+) and to measure the apoptotic
markers exclusively in those cells (Figure 6A, B and 6C).
A) Annexin V/PI staining
O n eo ft h ee a r l ys i g n so fa p o p t o s i si st r a n s l o c a t i o no f
phosphatidylserine (PS) from the inner to the outer leaf-
let of the plasma membrane. Annexin V specifically
binds to the surface-exposed PS of apoptotic cells. Flow
cytometry assay of Cy5-coupled Annexin V surface
binding showed an increase in the number of annexin
V
+/PI
- cells in transfected YFP
+ cells in the case of
R280C and L101P mutations when compared to WT
and R43L indicating an early apoptotic state of those
cells (Figure 6A).
B) GSH decrease
Glutathione is an essential low-molecular-weight thiol
and a major component of the cell antioxidant system
[34]. Loss of intracellular GSH is an early hallmark of
apoptosis progression and a part of early changes for
generation of a permissive environment for the activa-
tion of apoptotic enzymes [35]. Intracellular GSH level,
measured by flow cytometry of monochlorobimane
binding to GSH and generation of a fluorescent adduct,
was decreased in the YFP
+ cells with L101P protein
compared to YFP
+ WT, R43L and also compared to
R280C (Figure 6B).
C) Caspase 3 activation
Activation of caspase 3 is a late apoptotic marker. Cas-
pases are a family of proteins present in the cell as inac-
tive precursors and activated through a cascade of
regulated proteolytic cleavages leading to controlled cell
death [36]. Caspase 3 is one of the executioner caspases
activated at the end of the cascade. Via flow cytometry
assay of intracellular active caspase 3 we found an
increase in caspase 3 activation in cells expressing ER
retained L101P mutant in comparison to the WT and
R43L cells (Figure 6C).
Figure 6 Apoptosis in A549 cells expressing L101P and R280
mutations. A549 cells were transfected with pEYFP-N1/ABCA3
plasmids and apoptotic markers were analysed by FACS in the
transfected (YFP
+) population of cells and A549 cells by assaying (A)
annexin V
+/propidium iodide (PI)
- staining, (B) intracellular (i.c.)
glutathione (GSH) level through coupling of monochlorobimane
with GSH, to determine early apoptosis, and (C) intracellular active
caspase 3 level (MFI), to detect late apoptosis. Elevated early and
late apoptotic markers were detectable in cells expressing L101P
mutation, and one early marker (Annexin V) in cells expressing
R280C mutation. Results were calculated from six independent
experiments; * p < 0.05, ** p < 0.01, *** p < 0.001.
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totic signaling above the A549 or WT level, R280C
mutation increased one early apoptotic marker and ER-
localized L101P mutations significantly elevated early
and late apoptotic markers, indicating injury of the cells
with L101P protein.
Prolonged ER stress leads to apoptosis through caspase 4
activation in cells expressing R280C and L101P mutations
To examine if initiation of apoptosis in cells with
ABCA3 mutations is indeed a consequence of the ER
stress signaling, we assessed activation of caspase 4,
which is activated by apoptotic stimuli that cause ER
stress, but not other apoptotic stimuli [28,37]. Cleavage
of caspase 4 leads to proteolytic activation of execu-
tioner caspase 3 and to cell elimination. Therefore,
activation of caspase 4 identifies ER stress as an apopto-
sis trigger. Treatment of A549 cells with apoptosis indu-
cing cytokine TNFa resulted in the cleavage of caspase
4 (Figure 7A, B and 7C). Immunoblotting of whole cell
lysates from the cells expressing WT or R43L, R280C or
L101P mutations showed insignificant changes in pro-
caspase 4 level between WT and mutations, but the
level of pro-caspase 4 was somewhat higher in trans-
fected cells then in A549 (Figure 7B). In contrast,
cleaved caspase 4 in R280C and L101P mutants
increased significantly in comparison to WT. Changes
measured between R43L and WT were not significant
(Figure 7C). This shows that caspase 4 is involved in
apoptotic signaling in cells with L101P and R280C
mutations and that activation of the apoptotic pathway
can be a consequence of the ER stress caused by com-
plete or partial ER retention of the ABCA3 protein.
Discussion
ABCA3 mutations cause surfactant deficiency and fatal
respiratory distress syndrome in full-term neonates [10]
and chronic ILD of children [12,16,17]. The cellular
pathomechanisms of ABCA3-related chronic ILD are
probably complex including influence of ABCA3 muta-
tions on surfactant homeostasis but possibly also on the
fitness and function of AECII as cells for surfactant pro-
duction, lung repair and immunological defense [38].
In this study we investigated the influence of three
ABCA3 mutations, R43L, R280C and L101P, on intracel-
lular stress and induction of apoptosis in cultured lung
epithelial A549 cells. All three mutations were found in
children with ABCA3-associated lung disease being
either fatal neonatal respiratory distress syndrome
(L101P and R43L [10,14]) or chronic ILD (R280C; own
unpublished data, [19]). While cell biology of R43L and
R280C mutations was studied here for the first time,
L101P mutation was used as a known example of the
trafficking/folding defect leading to the ER retention of
ABCA3 with no information on ER stress [6,20].
Initial characterization in A549 cells demonstrated
that each of the mutations affected the ABCA3 trans-
porter in a different way. We showed correct localiza-
tion of WT and R43L proteins in LAMP3
+ vesicles and
dual localization of R280C protein in LAMP3
+ vesicles
Figure 7 Apoptotic signaling in cells with L101P and R280C
mutations is activated by ER stress. (A) Immunoblotting on
whole cell lysates from A549 cells transfected with pEYFP-N1/ABCA3
and densitometric analyses of (B) pro-caspase 4 and (C) cleaved
caspase 4 demonstrated increased caspase 4 cleavage in cells
expressing L101P and R280C mutations, as well as after TNFa
treatment of A549 (25 ng/ml, 16 h) in comparison to WT and
untreated A549. No significant changes in the pro-caspase 4 level in
transfected cells with WT, R43L, R280C and L101P mutations were
detected but pro-caspase 4 was slightly increased in transfected
cells compared to A549 (B). * - unknown band. Six independent
experiments were used for densitometric evaluation; * p < 0.05,
** p < 0.01.
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+ ER compartment (Figure 1A, B and 1C),
indicating less efficient but not abolished R280C traf-
ficking. Similar dual localization is known in the case of
other ABCA3 mutants as G122S [6]. R43L and R280C
proteins showed WT-processing with two protein bands
(Figure 2A) and presence of complex oligosaccharides
(Figure 2B) confirming their ability to proceed from the
ER to the Golgi. L101P protein remained in the ER, hav-
ing therefore no complex sugars, and no smaller 180
kDa protein form (Figure 1B and 2A, B) [6,20].
While ER retention of L101P excludes ABCA3 func-
tion, the function of R43L and R280C transporters was
studied additionally. Since ABCA3 is involved in lamel-
lar body biogenesis [7], in A549 cells, which normally
have a low number of compact LAMP3
+ vesicles,
expression of ABCA3-WT induced biogenesis of
LAMP3
+ vesicles by increasing their number and size
(Figure 3D) [9]. In addition, ABCA3-WT signal was
observed as ring-like structures consistent with the
ABCA3 presence in the limiting membrane of lamellar
bodies (Figure 1 and 3) [5]. In contrast to the WT,
expression of ABCA3 mutations, especially L101P,
impaired biogenesis of LAMP3
+ vesicles by reducing
their number and size (Figure 3D). This can be a conse-
quence of the inability of these mutated transporters to
effectively load lipids into the nascent lamellar bodies.
The uptake assay of NBD-labeled phospholipids PC
and PE into ABCA3-HA-positive vesicles demonstrated
frequent overlap of the NBD signal, both PC and PE
coupled, with the ring-like ABCA3-WT fluorescence
and its accumulation in the inner space of the WT-
ABCA3 vesicles (Figure 3A, B and 3C). In the case of
R43L and R280C mutations such colocalization was
rarely observed suggesting functional impairment of
R43L and R280C proteins. Similar uptake experiments
have been previously described [6]. In contrast to those
data, which show diffuse distribution of NBD-PC and
NBD-PE fluorescence throughout the cytoplasm, we
detected numerous distinct NBD-positive vesicles
(Figure 3A, B). The uptake and number of NBD-vesicles
observed in the cytoplasm was similar for both phos-
pholipids in A549 cells and in transfected A549, and
was also independent of the ABCA3 mutation, including
L101P. This confirms that for the liposome/lipid uptake
through the plasma membrane into the cytoplasm
ABCA3 function is dispensable and ABCA3 is solely an
intracellular vesicular transporter. Furthermore, we
observed an impact of ABCA3 mutations on the uptake
of both PC and PE. This parallels data published in
Cheong et al. (2007) [7] which demonstrated decreased
incorporation of radiolabeled PC and PE into the lamel-
lar bodies and surfactant of the ABCA3 heterozygote
mouse, consistent with a role of ABCA3 in the transport
of both phospholipid species. However, this is also in
contrast to Cheong et al. (2006) [6] showing no uptake
of NBD-PE into the lysosome-like vesicles in A549 cells.
Therefore, we must point out that it is questionable if
the PE transport through functional ABCA3 actually
happens in vivo or only in an in vitro system after
exposing cultured A549 cells to NBD lipids.
Continuous overload of the ER compartment with
misfolded proteins is harmful for the cell and can trigger
apoptotic cell death [22]. L101P protein which accumu-
lates in the ER, caused significant increase of the ER
stress and early and late apoptosis markers in the A549
cells (Figure 4, 5 and 6). The ER stress caused by R280C
mutation was slightly lower and surface staining with
annexin V, as an early apoptosis sign, was the only
apoptotic marker detected in R280C cells. This might be
ac o n s e q u e n c eo fad u a ln a t u r eo ft h i sp r o t e i nw h i c h
could be less harmful for the cell than complete ER
retention of ABCA3 and/or possible dependency of the
magnitude of its intracellular effects on small unma-
nageable inconsistencies of an experimental system. The
connection between ER stress and apoptosis induction
was established through the upregulation of caspase 4 in
the case of both L101P and R280C mutations (Figure 7).
Correctly localized R43L mutation, despite its influence
on the ABCA3 function and lamellar body biogenesis,
had almost no impact on stress and apoptosis under any
conditions above the range of the WT values (Figure 4,
5, 6 and 7).
ER stress-dependent signaling, examined via XBP1
splicing, was enhanced by exposure of transfected cells
to tunicamycin, an ER stressor (Figure 5B, E). In this
way the stress pressure imposed on the cells was
doubled: 1) genetic background of the ABCA3 mutations
and 2) exposure to the stress-causing agent. The cells
with mutations R280C and L101P, which impair ABCA3
trafficking, were more prone to further XBP1 splicing
than the WT or A549. This is interesting if known that
viral infections (e.g. RSV, herpes virus) or cigarette
smoke are common outside factors which, as tunicamy-
cin, elevate ER stress [39,40]. Doan et al. (2007) [12]
observed onset of ABCA3-associated ILD in children
following exposure to cigarette smoke and Young et al.
(2008) [16] described a teenage patient with a late onset
of ABCA3-related disease with fibrosis following the
beginning of cigarette consumption. If ABCA3 muta-
tions can raise susceptibility of AECII to external stress,
additional exposure to outside stressors as respiratory
viral infections or smoke might contribute to or even
trigger genetic ILD.
Misfolding and ER retention of other lipid ABC trans-
porters of the A subfamily, as ABCA1 and ABCA4,
cause Tangier disease and Stargardt macular dystrophy,
respectively [41,42], but their influence on ER stress and
apoptosis is unknown. The most common mutation
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CFTR/ABCC7, leading to cystic fibrosis, results in CFTR
misfolding and retention in the ER, and can raise stress
and activate UPR [43]. The concept that ER stress and
apoptosis lead to lung disease has been explored
recently when it was demonstrated that ER stress and
apoptosis of AECII are involved in the injury of lung
epithelium in idiopathic pulmonary fibrosis and SP-C
deficiency [25,26]. Also, expression of SP-C mutations
resulting in proSP-C misfolding and aggregation
increases ER stress, activates UPR and induces apoptosis
in A549 or HEK293 cells [27,28]. SP-C and ABCA3 are
both AECII-expressed proteins essential for surfactant
homeostasis and both lead to genetic ILD equally vari-
able in the age of onset, severity and pathology [44].
Therefore, it is interesting to see that the common
mechanisms underlying both types of genetic ILD must
exist and our data show that they probably encompass
the ER stress and apoptosis of AECII.
Conclusion
Apparently, the effect of ABCA3 mutations on homeos-
tasis of lung epithelial cells depends on the type of the
ABCA3 protein defect. More work is necessary to verify
if ER stress and apoptosis of AECII are indeed present
in (fibrotic) lung tissue of patients with ABCA3 muta-
tions. This might help to understand or even predict the
disease course, or consider new therapy options (as pro-
tein rescue with chaperones) depending on the type of
the ABCA3 protein defect. In conclusion, we have pre-
sented the cell biology study of two new ABCA3 muta-
tions and demonstrated that those mutations which
influence partially or completely ABCA3 trafficking raise
intracellular stress and susceptibility to it, and induce
apoptotic cell death signaling. Similar as proposed for
SP-C deficiency, intracellular stress and apoptosis of
A E C I Im i g h tp l a yar o l ei np a t h o g e n e s i so fA B C A 3 -
related lung disease.
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